Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IQV - IQVIA HOLDINGS INC.


Close
199.14
-0.610   -0.306%

Share volume: 19,655
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.90%

PREVIOUS CLOSE
CHG
CHG%

$199.75
-0.61
-0.31%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 34%
Dept financing 48%
Liquidity 52%
Performance 74%
Company vs Stock growth
vs
Performance
5 Days
0.57%
1 Month
-0.59%
3 Months
-14.71%
6 Months
-5.88%
1 Year
-13.66%
2 Year
-1.33%
Key data
Stock price
$199.14
P/E Ratio 
32.23
DAY RANGE
$198.62 - $201.04
EPS 
$7.71
52 WEEK RANGE
$193.20 - $261.73
52 WEEK CHANGE
-$13.45
MARKET CAP 
45.858 B
YIELD 
N/A
SHARES OUTSTANDING 
182.300 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,594,161
AVERAGE 30 VOLUME 
$1,440,684
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news